MannKind | MNKD - Passività Correnti





Passività Correnti Cambiamento Data
Adma Biologics USD 95.28M 19.52M 2026-09
BioCryst Pharmaceuticals USD 195.83M 13.02M 2026-09
Eli Lilly USD 47B 745M 2026-09
Halozyme Therapeutics USD 476.09M 131.65M 2026-09
Insmed USD 596.57M 157.83M 2026-09
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
MacroGenics USD 107.23M 1.58M 2026-09
MannKind USD 108.52M 34.37M 2026-09
Merck USD 28.8B 1.07B 2026-09
Minerva Neurosciences USD 2.29M 381K 2025-12
Novavax USD 329.84M 729K 2026-09
Novo Nordisk DKK 36.54B 188.62B 2026-06
Pfizer USD 31.73B 920M 2026-09
Sanofi EUR 29.77B 2.16B 2026-09
Xencor USD 76.27M 5.6M 2026-09